ArticleThe World Allergy Organization journal2023

Real-world evidence for the effectiveness and safety of dupilumab in patients with CRSwNP after 1 year of therapy.

Tobias Albrecht et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.